BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17/07/2015

FDA Releases Draft Guidance on Testicular Toxicity Evaluation During Drug Development

The FDA has released a draft guidance to help pharmaceutical companies identify potential testicular toxicity in their drugs and monitor adverse effects early in clinical trials.

Source: Federal Register — Food and Drug AdministrationOpen original release →